scholarly journals Metabolic Fingerprint of Acromegaly and its Potential Usefulness in Clinical Practice

2019 ◽  
Vol 8 (10) ◽  
pp. 1549 ◽  
Author(s):  
Biagetti ◽  
Herance ◽  
Ferrer ◽  
Aulinas ◽  
Palomino-Schätzlein ◽  
...  
Keyword(s):  
Clinical Course ◽  
Serum Levels ◽  
Therapeutic Strategies ◽  
Control Group ◽  
Metabolic Fingerprint ◽  
Close Relationship ◽  
Low Levels ◽  
Branched Chain ◽  
Metabolomic Approach ◽  
Active Disease

Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) levels are the main targets for monitoring acromegaly activity, but they are not in close relationship with the clinical course of the disease and the associated comorbidities. The present study was aimed at identifying metabolites that could be used as biomarkers for a better disease phenotyping. For this purpose, metabolic fingerprint using an untargeted metabolomic approach was examined in serum from 30 patients with acromegaly and 30 age-matched controls. Patients with acromegaly presented fewer branched-chain amino acids (BCAAs) compared to the control group (valine: 4.75 ± 0.87 vs. 5.20 ± 1.06 arbitrary units (AUs), p < 0.05; isoleucine: 2.54 ± 0.41 vs. 2.80 ± 0.51 AUs; p < 0.05). BCAAs were also lower in patients with active disease compared to patients with normal levels of IGF-1 with or without medical treatment. GH, but not IGF-1, serum levels were inversely correlated with both valine and isoleucine. These findings indicate that low levels of BCAAs represent the main metabolic fingerprint of acromegaly and that GH, rather than IGF-1, might be the primary mediator. In addition, our results suggest that the assessment of BCAAs could help to identify active disease and to monitor the response to therapeutic strategies.

scholarly journals Effect of Proinflammatory Cytokines (IL-6, TNF-α, and IL-1β) on Clinical Manifestations in Indian SLE Patients

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Vinod Umare ◽  
Vandana Pradhan ◽  
Milind Nadkar ◽  
Anjali Rajadhyaksha ◽  
Manisha Patwardhan ◽  
...  
Keyword(s):  
Proinflammatory Cytokines ◽  
Lupus Erythematosus ◽  
Clinical Manifestations ◽  
Serum Levels ◽  
Organ Damage ◽  
Inactive Disease ◽  
Control Group ◽  
Healthy Controls ◽  
Sledai Score ◽  
Active Disease

Systemic lupus erythematosus (SLE) is an inflammatory rheumatic disease characterized by production of autoantibodies and organ damage. Elevated levels of cytokines have been reported in SLE patients. In this study we have investigated the effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in 145 Indian SLE patients. One hundred and forty-five healthy controls of the same ethnicity served as a control group. Clinical disease activity was scored according to SLEDAI score. Accordingly, 110 patients had active disease and 35 patients had inactive disease. Mean levels of IL-6, TNF-α, and IL-1βwere found to be significantly higher in SLE patients than healthy controls (P<0.001). Mean level of IL-6 for patients with active disease (70.45±68.32 pg/mL) was significantly higher (P=0.0430) than those of inactive disease patients (43.85±63.36 pg/mL). Mean level of TNF-αwas44.76±68.32 pg/mL for patients with active disease while it was25.97±22.03 pg/mL for those with inactive disease and this difference was statistically significant (P=0.0161). Similar results were obtained for IL-1β(P=0.0002). Correlation between IL-6, TNF-α, and IL-1βserum levels and SLEDAI score was observed (r=0.20,r=0.27, andr=0.38, resp.). This study supports the role of these proinflammatory cytokines as inflammatory mediators in active stage of disease.

scholarly journals The association of low serum salivary and pancreatic amylases with the increased use of lipids as an energy source in non-obese healthy women

2020 ◽  
Author(s):  
Kei Nakajima ◽  
Ryoko Higuchi ◽  
Taizo Iwane ◽  
Ayaka Iida
Keyword(s):  
Energy Production ◽  
Serum Levels ◽  
Glycated Haemoglobin ◽  
High Serum ◽  
Hydroxybutyric Acid ◽  
Acetoacetic Acid ◽  
Close Relationship ◽  
Low Levels ◽  
Low Serum ◽  
Hba1c Levels

Abstract OBJECTIVE: It is unknown whether low serum levels of salivary and pancreatic amylases are associated with the high combustion of carbohydrates or lipids for energy. Elevated blood ketones and a low respiratory quotient (RQ) can reflect the preferential combustion of lipids relative to carbohydrates. Therefore, using the data from our previous study, we investigated if low levels of serum amylases were associated with a high serum ketone level and low RQ in 60 healthy non-obese young women aged 20–39 years old.RESULTS: Serum ketones [3-hydroxybutyric acid (3-HBA) and acetoacetic acid (AA)] were inversely correlated with RQs, but not body mass index (BMI) or glycated haemoglobin (HbA1c) levels. Logistic regression analysis showed that high levels of serum ketones (3-HBA ≥ 24 μmol/L and AA ≥ 17 μmol/L) and a low RQ (< 0.766) were significantly associated with low serum salivary (< 60 U/L) and pancreatic (< 29 U/L) amylase levels, respectively. These associations were not altered by further adjustments for age, BMI, HbA1c, and estimated glomerular filtration rate. These results confirm the high combustion of lipids for energy in individuals with low serum amylase levels, suggesting a close relationship between circulating amylases and internal energy production.

scholarly journals The association of low serum salivary and pancreatic amylases with the increased use of lipids as an energy source in non-obese healthy women

2020 ◽  
Author(s):  
Kei Nakajima ◽  
Ryoko Higuchi ◽  
Taizo Iwane ◽  
Ayaka Iida
Keyword(s):  
Energy Production ◽  
Serum Levels ◽  
Glycated Haemoglobin ◽  
High Serum ◽  
Hydroxybutyric Acid ◽  
Acetoacetic Acid ◽  
Close Relationship ◽  
Low Levels ◽  
Low Serum ◽  
Hba1c Levels

Abstract OBJECTIVE It is unknown whether serum levels of salivary and pancreatic amylases are associated with the high combustion of carbohydrates or lipids for energy. Elevated blood ketones and a low respiratory quotient (RQ) can reflect the preferential combustion of lipids relative to carbohydrates. Therefore, we investigated if low levels of serum salivary and pancreatic amylases were associated with a high serum ketone level and low RQ in healthy people. RESULTS Using the data from our previous study, we reanalysed clinical parameters, including serum salivary and pancreatic amylases, serum 3-hydroxybutyric acid (3-HBA) and acetoacetic acid (AA), and RQ in 60 healthy non-obese young women aged 20–39 years old. Serum ketones were inversely correlated with RQs, but not body mass index (BMI) or glycated haemoglobin (HbA1c) levels. Logistic regression analysis showed that high levels of serum ketones and a low RQ were significantly associated with low serum salivary (<60 U/L) and pancreatic (<29 U/L) amylase levels. These associations were not altered by further adjustments for age, BMI, HbA1c, and estimated glomerular filtration rate. These results confirm the high combustion of lipids for energy in individuals with low serum amylase levels, suggesting a close relationship between circulating amylases and internal energy production.

scholarly journals Features of immune response in children with varying severity of atopic dermatitis

2021 ◽  
Vol 16 (1) ◽  
pp. 20-26
Author(s):  
S.M. Nedelska ◽  
D.O. Vakula
Keyword(s):  
Immune Response ◽  
Atopic Dermatitis ◽  
Age Groups ◽  
Statistical Processing ◽  
Serum Levels ◽  
Young Age ◽  
Control Group ◽  
Healthy Children ◽  
Th2 Immune Response ◽  
Low Levels

Background. Atopic dermatitis (AD) is the most common allergic disease among children of young age. Severe forms of AD with skin bacterial and fungal overgrowth may be associated with features of the immune response in different age groups. Plenty of studies demonstrated not only polarization of the Th2 immune response in AD patients, but also the Th1 immune dysregulation. The purpose of this study was to investigate the features of the immune response in children with varying severity of atopic dermatitis. Materials and methods. The study included 85 children aged 3 months to 3 years with a verified diagnosis of AD, living in the Zaporozhzhia region. Twenty healthy children without atopy formed a control group. The patients were divided into groups depending on the severity of AD based on the SCORAD scale. The serum levels C3, C4–2, CD3+, CD19–, CD4+, CD8–, CD4–, CD8+, CD3–, CD56+, CD19+, CD14, CD45, IgA, IgM, IgG, IgE, С3, С4–2, phagocytic acti­vity of neutrophils, and proliferative activity of lymphocytes were measured by flow cyto­metry (Synevo). ELISA method was used to detect serum levels of IL-13 (ELISA Kit, Thermo Fisher Scientific, Austria). Statistical processing of the results was performed using the official software package Statistica 13.0. Results. The study revealed eosinophilia in 60 % of the children with a mild and moderate course of AD (Me 5.62 [3.64; 7.81]) and in 56 % of the children with a severe course (Me 6.18 [3.13; 9.42]). The children with a severe course of AD and low levels of IL-13, C3 had transient hypogammaglobulinemia and significantly lower le­vels of the C3 complement, increased levels of CD4+, CD8– with simultaneously decreased levels of CD4–, CD8+ compared with groups of the children with high levels of ­IL-13 (р < 0.05). Conclusion. The results suggest that severe forms of AD in children of the young age were associated with changes in the complement system and low levels of cytotoxic cells, transient hypogammaglobulinemia. It requires deeper research of the cascades of the immune response in children with AD.

scholarly journals Anosmia and dysgeusia among COVID-19 patients are associated with low levels of serum Glucagon-like peptide 1 (GLP-1)

2021 ◽  
Author(s):  
Eli Ben-Chetrit ◽  
Ami Ben Yaa'cov ◽  
Ahamad Quiteineh ◽  
Ohad Atia ◽  
Eran Regev ◽  
...  
Keyword(s):  
Nasal Congestion ◽  
Serum Levels ◽  
Study Groups ◽  
Underlying Mechanism ◽  
Enzyme Linked Immunosorbent Assay ◽  
Control Group ◽  
Lower Serum ◽  
Glucagon Like Peptide ◽  
Low Levels ◽  
Glucagon Like Peptide 1

Purpose: Anosmia and dysgeusia (AD) are common among COVID-19 patients. These symptoms are not frequently associated with rhinorrhea or nasal congestion and the underlying mechanism is unclear. Previous reports suggested that Glucagon-like peptide-1 (GLP-1) signaling plays a role in the modulation of olfaction and geusia. We aimed to assess the correlation between GLP-1 and COVID-19-associated AD. Methods: Blood samples obtained from COVID-19 patients with and without AD were tested for serum GLP-1 levels using enzyme-linked immunosorbent assay (ELISA). A second control group comprised of COVID-19-negative volunteers. Results: Forty-nine subjects were included in the study. Nineteen were positive for COVID-19. Of the 19 patients, ten had AD and nine declined such complaints. Age and basic metabolic rate were similar among all study groups. Serum GLP-1 levels were significantly lower among patients with AD as compared with patients without AD and COVID-19-negative individuals (1820 pg/ml vs 3536 pg/ml vs 3014 pg/ml, respectively, p<0.02). Conclusion: COVID-19 patients who reported of AD had lower serum levels of GLP-1 as compared with those lacking AD symptoms and COVID-19-negative individuals. These results suggest that GLP-1 may be involved in the pathogenesis of AD. However, further larger scale studies should corroborate our findings

scholarly journals Metabolic Fingerprint of Turner Syndrome

2020 ◽  
Vol 9 (3) ◽  
pp. 664
Author(s):  
Jolanta Bugajska ◽  
Joanna Berska ◽  
Małgorzata Wójcik ◽  
Jerzy B. Starzyk ◽  
Krystyna Sztefko
Keyword(s):  
Amino Acids ◽  
Turner Syndrome ◽  
Standard Deviation Score ◽  
Aromatic Amino Acids ◽  
Serum Levels ◽  
Control Group ◽  
Study Group ◽  
Mean Values ◽  
Increased Risk ◽  
Metabolic Fingerprint

Girls with Turner syndrome (TS) are at increased risk of developing insulin resistance and coronary artery disease as a result of hypertension and obesity frequently seen in these patients. On the other hand, it is known that obesity is associated with increased serum levels of branched-chain amino acids (BCAAs: valine; leucine and isoleucine) and aromatic amino acids. The aim of the study is to compare the metabolic fingerprint of girls with TS to the metabolic fingerprint of girls with obesity. Metabolic fingerprinting using an untargeted metabolomic approach was examined in plasma from 46 girls with TS (study group) and 22 age-matched girls with obesity (control group). The mean values of BCAAs, methionine, phenylalanine, lysine, tryptophan, histidine, tyrosine, alanine and ornithine were significantly lower in the study group than in the control (p from 0.0025 to <0.000001). Strong significant correlation between BCAAs, phenylalanine, arginine, tyrosine, glutamic acid, citrulline and alanine, and body mass index expressed as standard deviation score BMI-SDS in the patients with obesity (p from 0.049 to 0.0005) was found. In contrast; there was no correlation between these amino acids and BMI-SDS in the girls with TS. It is suggested that obesity in patients with TS is not associated with altered amino acids metabolism.

Low Levels of Pyridoxal 5'-Phosphate in Patients With Cystic Fibrosis

PEDIATRICS ◽  
1986 ◽  
Vol 78 (2) ◽  
pp. 278-282
Author(s):  
Bahjat A. Faraj ◽  
Daniel B. Caplan ◽  
Vernon M. Camp ◽  
Edith Pilzer ◽  
Michael Kutner
Keyword(s):  
Cystic Fibrosis ◽  
Vitamin B6 ◽  
Active Form ◽  
Serum Levels ◽  
Hepatic Disease ◽  
Biologically Active ◽  
Control Group ◽  
Hospitalized Children ◽  
Low Levels

To determine the effect of cystic fibrosis on the regulation of plasma pyridoxal 5'-phosphate (PLP), the biologically active form of vitamin B6, we measured this compound in plasma from 56 patients with cystic fibrosis. The concentration of PLP in plasma was assayed by a radioenzymatic technique. The results of this study showed that PLP concentration was decreased significantly (6.44 ± 5.20 ng/mL, mean ± SD; median 4.45 ng/mL) in patients with cystic fibrosis as compared with a group of hospitalized children with neither cystic fibrosis nor hepatic disease serving as a control group (13.2 ± 5.04 ng/mL, mean ± SD; median 12.5 ng/mL). Additionally, 25% of the population with cystic fibrosis exhibited exceedingly low plasma PLP level (less than 2.75 ng/mL). In patients with cystic fibrosis, significant inverse linear associations were found between plasma PLP and serum levels of SGOT and SGPT (PLP v SGOT: r = -. 60, P &lt; .03; PLP v SGPT: r = -.50, P &lt; .03). This study demonstrated that a deficiency of plasma PLP is a common abnormality in cystic fibrosis and that the low PLP level may be a reflection of impaired vitamin B6 metabolism associated with this disorder.

scholarly journals Evaluating vaspin and adiponectin in postmenopausal women with endometrial cancer

2013 ◽  
Vol 20 (5) ◽  
pp. 669-675 ◽  
Author(s):  
Serpil Erdogan ◽  
Sevilay Sezer ◽  
Eralp Baser ◽  
Ozlem Gun-Eryilmaz ◽  
Tayfun Gungor ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Endometrial Cancer ◽  
Postmenopausal Women ◽  
Serum Levels ◽  
Control Group ◽  
Study Group ◽  
Model Assessment ◽  
Increased Risk ◽  
Low Levels ◽  
Index Value

Insulin resistance is a well-documented risk factor for the development of endometrial cancer. Adiponectin and vaspin are insulin-sensitizing proteins that are secreted from adipose tissue. A clear association between serum levels of adipokines and endometrial cancer has yet to be established. The study group consisted of postmenopausal women with confirmed endometrial cancer, whereas patients with benign endometrial conditions constituted the control group. The two groups were compared in terms of insulin resistance and serum levels of adiponectin and vaspin. A total of 60 patients with confirmed endometrial cancer and 70 controls with benign endometrial conditions (polyps and atrophy) were enrolled. Median homeostasis model assessment of insulin resistance value was significantly higher in the study group compared with the control group (2.93 vs 1.27, P<0.0001), whereas mean quantitative insulin sensitivity check index value was significantly lower (0.33±0.02 vs 0.37±0.37, P<0.0001). Median values for both adiponectin and vaspin were significantly lower in patients with endometrial cancer compared with the control group (4.09 vs 17.13 μg/ml, P<0.0001 and 0.21 vs 0.39 ng/ml, P<0.0001 respectively). Low levels of both adiponectin and vaspin were found to be significantly associated with an increased risk for endometrial cancer. Following adjustment for confounding factors, the respective odds ratios for endometrial cancer in patients in the first tertile compared with those in the third tertile were 10.80 (2.76–42.24; P=0.001) and 13.23 (2.94–59.64; P=0.001). Our results show that lower levels of circulating adiponectin and vaspin levels are associated with an increased risk of developing endometrial cancer.

scholarly journals Gene Expression Profiling of Mediators Associated with the Inflammatory Pathways in the Intestinal Tissue from Patients with Ulcerative Colitis

2020 ◽  
Vol 2020 ◽  
pp. 1-11 ◽  
Author(s):  
Gabriela Fonseca Camarillo ◽  
Emilio Iturriaga Goyon ◽  
Rafael Barreto Zuñiga ◽  
Lucero Adriana Salazar Salas ◽  
Ana Elena Peredo Escárcega ◽  
...  
Keyword(s):  
Gene Expression ◽  
Colonic Mucosa ◽  
Intestinal Inflammation ◽  
Clinical Course ◽  
Gene Expression Signature ◽  
Control Group ◽  
Mrna Levels ◽  
Gene Expressions ◽  
Inflammatory Pathways ◽  
Active Disease

Background. Multiple genes have been associated with IBD, and many of these can be linked to alterations in autophagy, UPR, ubiquitination, and metabolic and immune response pathways. The aim of this study was to analyze a transcriptomic panel of mediators associated with the inflammatory pathways in the colonic mucosa of UC patients. Patients and Methods. We studied a total of 100 patients with definitive diagnosis of UC (50 active and 50 in remission) and a control group (50 subjects) without endoscopic evidence of intestinal inflammation. Colonic mucosal biopsies were taken by colonoscopy and preserved in RNA later. Gene expression were measured by real-time polymerase chain reaction (RT-PCR). Results. The gene expressions of XBP1, AGR2, HSPA5, UBE2L3, TNFRSF14, LAMP3, FCGR2A, LSP1, CTLA4, SOD2, TDO2, and ALDOB mRNA levels were significantly higher in the colonic mucosa from UC patients (both quiescent and active) as compared to the control group (P<0.05). Conversely, IRGM, ORDML3, UBD, CUL2, CYLD, FOXC2, FOXO4, DOK3, and SNX20 mRNA levels were found to be significantly lower in patients with active disease, as compared to those with active disease (P<0.05). Gene expressions of IRGM, CTLA4, FOXO4, SLC26A3, SLC39A4, SOD2, TDO2, and ALDOB were associated with clinical outcomes, such as medical treatment in response to aminosalicylates, histological remission, clinical course, and evolution. Conclusions: The gene expressions of FOXO4, ALDOB, SOD2, TOD2, SLC26A3, and SLC39A4 were associated with the clinical course and histological activity and are of relevance since these provide the utility of new prognostic markers in IBD. Gene expression signature showed dysregulation in mediators associated with autophagy, ubiquitination, ER stress, oxidative stress, carbohydrate metabolism, solute transport, and T cell regulation in the colonic mucosa from patients with UC, suggesting that these genes could be involved in the pathogenesis of UC.

Diagnosis of congenital sexual maldevelopment in boys with bilateral inguinal cryptorchidism during minipuberty

2019 ◽  
Vol 65 (4) ◽  
pp. 236-242
Author(s):  
Nadezda Y. Raygorodskaya ◽  
Nina V. Bolotova ◽  
Marina L. Chekhonatskaya ◽  
Vadim K. Polyakov ◽  
Ludmila N. Sedova ◽  
...  
Keyword(s):  
Sex Hormones ◽  
Hypogonadotropic Hypogonadism ◽  
Molecular Genetic ◽  
Serum Levels ◽  
Inhibin B ◽  
Control Group ◽  
Group 3 ◽  
Low Levels ◽  
Group 2 ◽  
Group 1

BACKGROUND: Cryptorchidism is associated with the risk of infertility and can be a symptom of congenital sexual maldevelopment. AIM: To assess the functional status of the pituitary gland and sexual glands in boys aged 16 months with bilateral inguinal cryptorchidism and to reveal the congenital sexual maldevelopment during minipuberty. METHODS: Twenty-one boys aged 16 months (the minipuberty period) with isolated bilateral inguinal cryptorchidism and 40 healthy boys aged 23 months (the control group) were examined. The gonadal status was assessed and serum levels of sex hormones were measured. Molecular genetic testing was performed if there were indications for it. RESULTS: The results of hormone analysis were used to divide the patients into three groups: group 1 patients with normal serum levels of gonadotropin and sex hormones; group 2 patients with elevated gonadotropin level and low levels of anti-Mllerian hormone (AMH) and inhibin B, and group 3 patients with zero gonadotropin and testosterone levels and low levels of AMH and inhibin B. Group 1 patients had no functional disturbances in the pituitarygonadal system. Failure of Sertoli cells associated with a high risk of infertility was detected in group 2 patients. Group 3 patients were diagnosed with hypogonadotropic hypogonadism verified by molecular genetic tests. CONCLUSION: Hormonal testing of patients with bilateral inguinal cryptorchidism during minipuberty makes it possible to early detect the congenital sexual maldevelopment.

Sign in / Sign up

Export Citation Format

Share Document